Nasdaq

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
Nasdaq

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0") under CE Mark for self-test and professional use

Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® ...
Reuters

Roche launches lab antigen test to support high-volume COVID-19 testing

ZURICH (Reuters) -Roche said on Friday it launched a laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients, as very high demand for tests prompts the Swiss ...
FiercePharma

Pandemic drug, shot and test makers Pfizer and Roche pen COVID awareness collab

Roche and Pfizer have launched a collaboration in the U.S. to help those who test positive for COVID-19 find the best resources for the best possible outcomes. Starting just in time for a potential ...
Reuters

Healthineers launches rapid coronavirus antigen test, sees tight supply

Healthineers competing with Roche, Abbott and others Antigen tests much cheaper and faster than PCR but less accurate Public health systems need wider testing to trace hotspots FRANKFURT, Oct 14 ...